Main > PNEUMOLOGY > Steroids. > Mometasone Furoate. > Patent. > Claims > Claim 1: Agglomeration Process > a) Provide: (i) Mometasone Furoate > Particles & (ii) Solid Binder. > (i) &/or (ii) have Amorphous Conten > t Convertable to Crystalline Form > upon Exposure to Stimulus > Formation Bridges between Particles > b) Agglomerating (i) & (ii) while > Maintaining Amorphous Content & c) > Exposing Amorphous Content to > Stimulus. Dosage Form. Adm. by > Oral Inhalation Therapy. Agglomera > te: Drug & Crystalline Solid Binder > Av. Particle Size<10 .mu.m.Av. Size > =400-700 .mu.m. Bulk d.=0.2-0.4 & > Crush Strength=200-1500 mg.

---

Crush Strength=200-1500 mg.'s subsections
Claim 5: Binder: Lactose. Claim 6:

Crush Strength=200-1500 mg.'s products
This section has no products